Energenesis Biomedical Co., Ltd. engages in the development of new drugs. Its business activities include sale of reagents, and testing and analysis services. It offers medicines for diabetic foot ulcers, and alopecia treatment. The company was founded by Jen Yi Chiu and Han Min Chen on August 28, 2012 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company